Tag: ESC 2022

ESC 2022: Findings of CAPLA trial “do not support inclusion of...

The addition of posterior wall isolation (PWI) does not improve arrhythmia outcomes compared with pulmonary vein isolation (PVI) alone in patients undergoing first time...

ESC 2022: Risk score predicts mortality for AF patients after TAVI

Researchers have developed a risk score to predict mortality for patients with atrial fibrillation (AF) who have undergone a successful transcatheter aortic valve implantation...

ESC 2022: Favourable results for Medtronic’s EV ICD system in pivotal...

Medtronic has announced that its investigational EV ICD system—a defibrillator with the lead placed under the breastbone, outside of the heart and veins—achieved a...

ESC 2022: Smartphone screening doubles AF detection rate in eBRAVE-AF

Screening for atrial fibrillation (AF) using a smartphone app more than doubled the detection and treatment rate in older people compared to routine screening,...

ESC 2022: AI outshines sonographer echocardiogram assessment in EchoNet-RCT

Results of one of the first and only randomised, blinded trials to assess the use of an artificial intelligence (AI) algorithm as an assessment...

ESC 2022: Guidelines call for public engagement in tackling sudden cardiac...

New guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death have been published today in the European...

ESC 2022: Medical cannabis users “at elevated risk” of arrhythmia

Cannabis prescribed for chronic pain is associated with an elevated risk of heart rhythm disorders, according to research presented at the European Society of...